Pharmaceuticals / services

Pharmaceutical

L-Ornithine-L-Aspartate

Release time:2021-12-12

Indications: 
For the treatment of hyperammonemia as a result of acute and chronic liver diseases such as liver cirrhosis, fatty liver, hepatitis; especially for the treatment of incipient disturbances of consciousness (pre-coma) or neurological complications (hepatic encephalopathy). 
 

Reprint statement: reprint please indicate "source: Wista pharma".

Back
Nitrofurantoin